이소트레티노인 약물 시장 : 2027년까지 예측

출판:Market Research Future(마켓츠리서치퓨처) 출판년월:2022년03월

Isotretinoin Drugs Market – Forecast till 2027
전 세계 이소트레티노인 약물 시장은 예측 기간 동안 4.68%의 상당한 CAGR을 기록하여 2027년 말까지 시장 가치 미화 16억 5240만 달러를 초과할 것으로 예상됩니다.

페이지수 115
가격
Single user license USD4,950
Enterprise License USD7,250
구성 영문조사보고서

리포트목차    주문/문의    납기/라이센스안내

Sample Request

Isotretinoin Drugs Market – Forecast till 2027
Market Forecast
The global isotretinoin drugs market is anticipated to register a significant CAGR of 4.68% during the forecast period to surpass a market value of USD 1,652.40 million by the end of 2027.

보고서 주요 목차

  • 연구 방법론
  • 시장 역학
  • 시장 요인 분석
  • 글로벌 이소트레티노인 의약품 시장, 형태별
  • 표시에 의한 글로벌 이소트레티노인 약물 시장
  • 유통 채널별 글로벌 이소트레티노인 의약품 시장
  • 지역별 글로벌 이소트레티노인 의약품 시장
  • 경쟁 구도

The global isotretinoin drug market is expected to register a notable market expansion during the review period owing to the growing incidences of acne among people and neuroblastoma. Additionally, the emergence of micronized formation for serious recalcitrant nodular acne cure creates lucrative scope for the global market. Besides, the concerns relating to drug side-effects are anticipated to hamper the global market growth.
The admission of isotretinoin drug presents wellbeing gambles among pregnant ladies. The medication can cause a few birth deformities, for example, the congenital fissure and inherent heart deserts among others. Likewise, unnatural birth cycle and stillbirth are a portion of the significant incidental effects set off by the utilization of the isotretinoin drug. Different confusions impeding the isotretinoin drugs market incorporate dry skin, seriously dried out lips, nosebleeds, dry and disturbed eyes, and dry mouth. The medicine was additionally answered to cause transitory secondary effects like deteriorating of skin inflammation, night visual impairment, diminishing hair, and muscle or joint agony. Also, rashes, stomach issues, and unfortunate cholesterol levels are the interesting conceivable aftereffects that singular encounters during the admission of isotretinoin drugs.
Market Segmentation
The Global Isotretinoin Drugs Market is classified based on Form, indication, distribution channel, and others. By form segment, the global market has been bifurcated into Injection and Capsule.
Based on Indication the market is classified into Severe acne, Squamous cell carcinoma, cutaneous T-cell lymphoma, Neuroblastoma, Harlequin ichthyosis, Xeroderma pigmentosum, and Fibrodysplasia ossificans progressive.
The Distribution Channel divides the market into three main types namely Hospital pharmacies, Retail Pharmacies, and Online pharmacies.
Region-Specific Analysis
North America represented a market size of USD 468.76 million of every 2020 and is relied upon to show a 5.06% CAGR during the review time frame. The isotretinoin drugs market is filling in the area because of created medical care framework, good unofficial laws, the rising pervasiveness of different skin issues, hereditary issues, and malignant growth, as well as expanded R&D venture.
The Asia-Pacific isotretinoin drugs market is relied upon to develop at a CAGR of 6.18% somewhere in the range of 2021 and 2027. The presence of a few market players in the region, for example, Sun Pharma organization (India) and Dr. Reddy’s Laboratories Ltd (India), is driving the territorial market development. Moreover, because of the expansion in financing from financial backers, the utilization of isotretinoin is ceaselessly ascending among the clients in more burdened regions, with Asia seeing a relatively higher expansion being used.
Major Players
The key players in the global isotretinoin drugs market are Teva Pharmaceuticals Industries, Akorn (US), Catalent Pharma Solutions (US), Chongqing Huapont (China), Inc. (Israel), Dr. Reddy’s Laboratories (India), Douglas Pharmaceuticals Ltd (New Zealand), F. Hoffmann La Roche (Europe)., Mylan (US), Cipher Pharmaceuticals (US), GlaxoSmithKline (UK), and Sun Pharmaceuticals (India).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.


목차

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF ACNE AMONG TEENS AND YOUNG ADULTS

4.2.2 INCREASING INCIDENCE OF NEUROBLASTOMA

4.3 RESTRAINT

4.3.1 CONCERNS PERTAINING TO DRUG SIDE EFFECTS

4.4 OPPORTUNITY

4.4.1 INTRODUCTION OF NEW MICRONIZED FORMATION FOR SEVERE RECALCITRANT NODULAR ACNE TREATMENT

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON ISOTRETINOIN DRUGS MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON THE ISOTRETINOIN DRUGS MARKET

5.3.3 IMPACT ON GDP AND HEALTHCARE EXPENDITURE

5.4 OFF LABEL USAGE OF ISOTRETINOIN CAPSULES

5.5 BY INDICAITION ANALYSIS ON PRESCRIBED PERSONNEL AND DOSAGE

6 GLOBAL ISOTRETINOIN DRUGS MARKET, BY FORM

6.1 OVERVIEW

6.2 CAPSULE

6.3 INJECTION

7 GLOBAL ISOTRETINOIN DRUGS MARKET, BY INDICATION

7.1 OVERVIEW

7.2 SEVERE ACNE

7.3 SQUAMOUS CELL CARCINOMA

7.4 CUTANEOUS T-CELL LYMPHOMA

7.5 NEUROBLASTOMA

7.6 HARLEQUIN ICHTHYOSIS

7.7 XERODERMA PIGMENTOSUM

7.8 FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

7.9 OTHERS

8 GLOBAL ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW

8.2 HOSPITAL PHARMACIES

8.3 RETAIL PHARMACIES

8.4 ONLINE PHARMACIES

9 GLOBAL ISOTRETINOIN DRUGS MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 UK

9.3.4 ITALY

9.3.5 RUSSIA

9.3.6 SPAIN

9.3.7 UKRAINE

9.3.8 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 JAPAN

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL ISOTRETINOIN DRUGS MARKET

10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL ISOTRETINOIN DRUGS MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT LAUNCHES/PRODUCT APPROVALS

10.6.2 EXPANSIONS

10.7 FINANCIAL MATRIX

10.7.1 SALES (USD MILLION), 2020

10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020

11 COMPANY PROFILES

11.1 DOUGLAS PHARMACEUTICALS LIMITED

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS/SERVICES OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 TEVA PHARMACEUTICAL INDUSTRIES LTD

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS/SERVICES OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 AKORN OPERATING COMPANY LLC

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS/SERVICES OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 KEY STRATEGIES

11.4 DR. REDDY’S LABORATORIES LTD

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS/SERVICES OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 F. HOFFMAN LA ROCHE LTD

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS/SERVICES OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 MYLAN NV

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS/SERVICES OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 SUN PHARMACEUTICALS

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.7.6 KEY STRATEGIES

11.8 CIPHER PHARMACEUTICALS INC.

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL ANALYSIS

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 KEY STRATEGIES

11.9 GLAXOSMITHKLINE PLC

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL ANALYSIS

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 SWOT ANALYSIS

11.9.6 KEY STRATEGIES

11.10 CHONGQING HUAPONT

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL ANALYSIS

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

11.11 CATALENT PHARMA SOLUTIONS

11.11.1 COMPANY OVERVIEW

11.11.2 FINANCIAL ANALYSIS

11.11.3 PRODUCTS OFFERED

11.11.4 KEY DEVELOPMENTS

11.11.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR CAPSULE, BY REGION, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR INJECTION, BY REGION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR SEVERE ACNE, BY REGION, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR SQUAMOUS CELL CARCINOMA, BY REGION, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR CUTANEOUS T-CELL LYMPHOMA, BY REGION, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR NEUROBLASTOMA, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR HARLEQUIN ICHTHYOSIS, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR XERODERMA PIGMENTOSUM, BY REGION, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: ISOTRETINOIN DRUGS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: ISOTRETINOIN DRUGS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 NORTH AMERICA: ISOTRETINOIN DRUGS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 21 NORTH AMERICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 22 NORTH AMERICA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 23 NORTH AMERICA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 24 US: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 25 US: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 26 US: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 27 CANADA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 28 CANADA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 29 CANADA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 30 EUROPE: ISOTRETINOIN DRUGS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 31 EUROPE: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 32 EUROPE: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 33 EUROPE: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 34 GERMANY: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 35 GERMANY: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 36 GERMANY: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 37 FRANCE: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 38 FRANCE: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 39 FRANCE: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 40 UK: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 41 UK: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 42 UK: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 43 ITALY: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 44 ITALY: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 45 ITALY: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 46 RUSSIA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 47 RUSSIA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 48 RUSSIA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 49 SPAIN: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 50 SPAIN: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 51 SPAIN: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 52 UKRAINE: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 53 UKRAINE: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 54 UKRAINE: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 55 REST OF EUROPE: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 56 REST OF EUROPE: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 57 REST OF EUROPE: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 58 ASIA-PACIFIC: ISOTRETINOIN DRUGS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 59 ASIA-PACIFIC: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 60 ASIA-PACIFIC: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 61 ASIA-PACIFIC: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 62 CHINA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 63 CHINA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 64 CHINA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 65 INDIA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 66 INDIA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 67 INDIA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 68 JAPAN: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 69 JAPAN: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 70 JAPAN: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 71 SOUTH KOREA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 72 SOUTH KOREA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 73 SOUTH KOREA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 74 AUSTRALIA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 75 AUSTRALIA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 76 AUSTRALIA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 77 REST OF ASIA-PACIFIC: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 78 REST OF ASIA-PACIFIC: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 79 REST OF ASIA-PACIFIC: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 80 REST OF THE WORLD: ISOTRETINOIN DRUGS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 81 REST OF THE WORLD: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 82 REST OF THE WORLD: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 83 REST OF THE WORLD: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 84 MIDDLE EAST: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 85 MIDDLE EAST: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 86 MIDDLE EAST: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 87 AFRICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 88 AFRICA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 89 AFRICA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 90 LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 91 LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 92 LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 93 MAJOR PLAYERS IN THE GLOBAL ISOTRETINOIN DRUGS MARKET

TABLE 94 MOST ACTIVE PLAYER IN THE GLOBAL ISOTRETINOIN DRUGS MARKET

TABLE 95 PRODUCT LAUNCHES/PRODUCT APPROVALS

TABLE 96 EXPANSIONS

TABLE 97 DOUGLAS PHARMACEUTICALS LIMITED: PRODUCTS/SERVICES OFFERED

TABLE 98 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED

TABLE 99 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS

TABLE 100 AKORN OPERATING COMPANY LLC: PRODUCTS/SERVICES OFFERED

TABLE 101 DR. REDDY’S LABORATORIES LTD: PRODUCTS/SERVICES OFFERED

TABLE 102 DR. REDDY’S LABORATORIES LTD: KEY DEVELOPMENTS

TABLE 103 F. HOFFMAN LA ROCHE LTD: PRODUCTS/SERVICES OFFERED

TABLE 104 MYLAN NV: PRODUCTS/SERVICES OFFERED

TABLE 105 SUN PHARMACEUTICALS: PRODUCTS OFFERED

TABLE 106 SUN PHARMACEUTICALS: KEY DEVELOPMENTS

TABLE 107 CIPHER PHARMACEUTICALS: PRODUCTS OFFERED

TABLE 108 GLAXOSMITHKLINE PLC: PRODUCTS OFFERED

TABLE 109 CHONGQING HUAPONT: PRODUCTS OFFERED

TABLE 110 CATALENT PHARMA SOLUTIONS: PRODUCTS OFFERED

TABLE 111 CATALENT PHARMA SOLUTIONS: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL ISOTRETINOIN DRUGS MARKET STRUCTURE

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL ISOTRETINOIN DRUGS MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ISOTRETINOIN DRUGS MARKET

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ISOTRETINOIN DRUGS MARKET

FIGURE 9 GLOBAL: ISOTRETINOIN DRUGS MARKET, BY FORM, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL: ISOTRETINOIN DRUGS MARKET, BY INDICATION, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: ISOTRETINOIN DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: ISOTRETINOIN DRUGS MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL: ISOTRETINOIN DRUGS MARKET SHARE (%), BY REGION, 2020

FIGURE 14 EUROPE: ISOTRETINOIN DRUGS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 15 EUROPE: ISOTRETINOIN DRUGS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 16 ASIA-PACIFIC: ISOTRETINOIN DRUGS MARKET SHARE (%), BY REGION, 2020

FIGURE 17 REST OF THE WORLD: ISOTRETINOIN DRUGS MARKET SHARE (%), BY REGION 2020

FIGURE 18 MAJOR MANUFACTURERS IN THE GLOBAL ISOTRETINOIN DRUGS MARKET

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ISOTRETINOIN DRUGS MARKET

FIGURE 21 GLOBAL ISOTRETINOIN DRUGS MARKET: COMPETITIVE LANDSCAPE

FIGURE 22 SALES, (USD MILLION), 2020

FIGURE 23 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020

FIGURE 24 DOUGLAS PHARMACEUTICALS LIMITED: SWOT ANALYSIS

FIGURE 25 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS

FIGURE 27 AKORN OPERATING COMPANY LLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 DR. REDDY’S LABORATORIES LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 DR. REDDY’S LABORATORIES LTD: SWOT ANALYSIS

FIGURE 30 F. HOFFMAN LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 F. HOFFMAN LA ROCHE LTD: SWOT ANALYSIS

FIGURE 32 MYLAN NV: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 FINANCIAL OVERVIEW

FIGURE 34 SUN PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 35 CIPHER PHARMACEUTICALS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 GLAXOSMITHKLINE PLC: SWOT ANALYSIS

FIGURE 38 CATALENT PARMA SOLUTIONS: FINANCIAL OVERVIEW SNAPSHOT


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com